MishraAMalikRHachiyaT, et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature2022; 611: 115–123.
3.
IbanezLHeitschLCarreraC, et al. Multi-ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke. Brain2022; 145: 2394–2406.
4.
LindgrenAG.Genomics of stroke recovery and outcome. J Cereb Blood Flow Metab2026; 46: 1297–1308.
5.
Gallego-FabregaCCullellNFernandez-CadenasI.How epigenetics impacts stroke risk and outcomes through DNA methylation: a systematic review. J Cereb Blood Flow Metab2026; 46: 1369–1385.
6.
StamovaBKneppBRodriguezF.Molecular heterogeneity in human stroke – what can we learn from the peripheral blood transcriptome?. J Cereb Blood Flow Metab2026; 46: 1424–1446.
7.
ShiRChenHZhangW, et al. Single-cell RNA sequencing in stroke and traumatic brain injury: current achievements, challenges, and future perspectives on transcriptomic profiling. J Cereb Blood Flow Metab2026; 46: 1447–1471.
8.
ChakkaraiSLe GrandQShaoxuanLW, et al. Unravelling the genetic architecture of cerebral small vessel disease in the context of stroke. J Cereb Blood Flow Metab2026; 46: 1386–1403.
9.
KimballTNTackRWChenA, et al. Genetics of intracerebral hemorrhage. J Cereb Blood Flow Metab2026; 46: 1324–1340.
10.
FaberJE.Genetic determinants of insufficiency of the collateral circulation. J Cereb Blood Flow Metab2026; 46: 1341–1368.
11.
DharRYuWYenariM, et al. Collateral flow: prolonging the ischemic penumbra. Transl Stroke Res2023; 14: 1–2.
12.
DaghlasIGillD.Leveraging Mendelian randomization to inform drug discovery and development for ischemic stroke. J Cereb Blood Flow Metab2026; 46: 1404–1423.
